Aktis Oncology
AKTSInsider trades and stock quote 2024-2026
All insider trades at Aktis Oncology
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 1/12/2026 | Buy | Ecor1 Capital, LLC | Director | $18.0 | $39,999,996 |
| 1/12/2026 | Buy | Kim, Helen Susan | Director | $18.0 | $15,030,000 |
| 1/12/2026 | Buy | Vida Ventures II, LLC | Ten Percent Owner | $18.0 | $15,030,000 |
| 1/12/2026 | Buy | Gadicke, Ansbert | Ten Percent Owner | $18.0 | $20,029,986 |
| 1/12/2026 | Buy | Mpm Bioventures 2018, L.p. | Ten Percent Owner | $18.0 | $20,029,986 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)